Skip to main content
Top
Published in: Angiogenesis 3/2021

Open Access 01-08-2021 | Metastasis | Original Paper

A novel lymphatic pattern promotes metastasis of cervical cancer in a hypoxic tumour-associated macrophage-dependent manner

Authors: Xiao-Jing Chen, Wen-Fei Wei, Zi-Ci Wang, Nisha Wang, Chu-Hong Guo, Chen-Fei Zhou, Luo-Jiao Liang, Sha Wu, Li Liang, Wei Wang

Published in: Angiogenesis | Issue 3/2021

Login to get access

Abstract

Lymphatic remodelling in the hypoxic tumour microenvironment (TME) is critically involved in the metastasis of cervical squamous cell carcinoma (CSCC); however, its underlying mechanisms remain unclear. Here, we uncovered a novel lymphatic pattern in the hypoxic TME, wherein lymphatic vessels (LVs) are encapsulated by tumour-associated macrophages (TAMs) to form an interconnected network. We describe these aggregates as LVEM (LVs encapsulated by TAMs) considering their advantageous metastatic capacity and active involvement in early lymph node metastasis (LNM). Mechanistic investigations revealed that interleukin-10 (IL-10) derived from hypoxic TAMs adjacent to LVs was a prerequisite for lymphangiogenesis and LVEM formation through its induction of Sp1 upregulation in lymphatic endothelial cells (LECs). Interestingly, Sp1high LECs promoted the transactivation of C–C motif chemokine ligand 1 (CCL1) to facilitate TAM and tumour cell recruitment, thereby forming a positive feedback loop to strengthen the LVEM formation. Knockdown of Sp1 or blockage of CCL1 abrogated LVEM and consequently attenuated LNM. Notably, CSCCnon-LNM is largely devoid of hypoxic TAMs and the resultant LVEM, which might explain its metastatic delay. These findings identify a novel and efficient metastasis-promoting lymphatic pattern in the hypoxic TME, which might provide new targets for anti-metastasis therapy and prognostic assessment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fluegen G, Avivar-Valderas A, Wang Y et al (2017) Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol 19:120–132PubMedPubMedCentralCrossRef Fluegen G, Avivar-Valderas A, Wang Y et al (2017) Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol 19:120–132PubMedPubMedCentralCrossRef
2.
go back to reference Martin JD, Fukumura D, Duda DG, Boucher Y, Jain RK (2016) Reengineering the tumor microenvironment to alleviate hypoxia and overcome cancer heterogeneity. Cold Spring Harb Perspect Med 6:a027094PubMedPubMedCentralCrossRef Martin JD, Fukumura D, Duda DG, Boucher Y, Jain RK (2016) Reengineering the tumor microenvironment to alleviate hypoxia and overcome cancer heterogeneity. Cold Spring Harb Perspect Med 6:a027094PubMedPubMedCentralCrossRef
3.
4.
go back to reference Stacker SA, Williams SP, Karnezis T et al (2014) Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer 14:159–172PubMedCrossRef Stacker SA, Williams SP, Karnezis T et al (2014) Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer 14:159–172PubMedCrossRef
8.
go back to reference Potente M, Makinen T (2017) Vascular heterogeneity and specialization in development and disease. Nat Rev Mol Cell Biol 18:477–494PubMedCrossRef Potente M, Makinen T (2017) Vascular heterogeneity and specialization in development and disease. Nat Rev Mol Cell Biol 18:477–494PubMedCrossRef
10.
12.
go back to reference Chen X, Wu J, Yan RM et al (2019) The role of the hypoxia-Nrp-1 axis in the activation of M2-like tumor-associated macrophages in the tumor microenvironment of cervical cancer. Mol Carcinog 58:388–397PubMedCrossRef Chen X, Wu J, Yan RM et al (2019) The role of the hypoxia-Nrp-1 axis in the activation of M2-like tumor-associated macrophages in the tumor microenvironment of cervical cancer. Mol Carcinog 58:388–397PubMedCrossRef
13.
go back to reference Murdoch C, Lewis CE (2005) Macrophage migration and gene expression in response to tumor hypoxia. Int J Cancer 117:701–708PubMedCrossRef Murdoch C, Lewis CE (2005) Macrophage migration and gene expression in response to tumor hypoxia. Int J Cancer 117:701–708PubMedCrossRef
14.
go back to reference Tudisco L, Orlandi A, Tarallo V, De Falco S (2017) Hypoxia activates placental growth factor expression in lymphatic endothelial cells. Oncotarget 8:32873–32883PubMedPubMedCentralCrossRef Tudisco L, Orlandi A, Tarallo V, De Falco S (2017) Hypoxia activates placental growth factor expression in lymphatic endothelial cells. Oncotarget 8:32873–32883PubMedPubMedCentralCrossRef
15.
go back to reference Karin N (2018) Chemokines and cancer: new immune checkpoints for cancer therapy. Curr Opin Immunol 51:140–145PubMedCrossRef Karin N (2018) Chemokines and cancer: new immune checkpoints for cancer therapy. Curr Opin Immunol 51:140–145PubMedCrossRef
17.
go back to reference Han L, Wang W, Fang Y et al (2009) Soluble B and T lymphocyte attenuator possesses antitumor effects and facilitates heat shock protein 70 vaccine-triggered antitumor immunity against a murine TC-1 cervical cancer model in vivo. J Immunol 183:7842–7850PubMedCrossRef Han L, Wang W, Fang Y et al (2009) Soluble B and T lymphocyte attenuator possesses antitumor effects and facilitates heat shock protein 70 vaccine-triggered antitumor immunity against a murine TC-1 cervical cancer model in vivo. J Immunol 183:7842–7850PubMedCrossRef
18.
go back to reference Garza-Morales R, Perez-Trujillo JJ, Martinez-Jaramillo E et al (2019) A DNA vaccine encoding SA-4-1BBL fused to HPV-16 E7 antigen has prophylactic and therapeutic efficacy in a cervical cancer mouse model. Cancers 11:96PubMedCentralCrossRef Garza-Morales R, Perez-Trujillo JJ, Martinez-Jaramillo E et al (2019) A DNA vaccine encoding SA-4-1BBL fused to HPV-16 E7 antigen has prophylactic and therapeutic efficacy in a cervical cancer mouse model. Cancers 11:96PubMedCentralCrossRef
19.
go back to reference Wu XG, Zhou CF, Zhang YM et al (2019) Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma. Angiogenesis 22:397–410PubMedCrossRef Wu XG, Zhou CF, Zhang YM et al (2019) Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma. Angiogenesis 22:397–410PubMedCrossRef
20.
go back to reference Shaikh S, Noshirwani A, West N, Perry S, Jayne D (2015) Can macrophages within the microenvironment of locally invasive rectal cancers predict response to radiotherapy? Lancet 385(Suppl 1):S87PubMedCrossRef Shaikh S, Noshirwani A, West N, Perry S, Jayne D (2015) Can macrophages within the microenvironment of locally invasive rectal cancers predict response to radiotherapy? Lancet 385(Suppl 1):S87PubMedCrossRef
22.
go back to reference Tjiu JW, Chen JS, Shun CT et al (2009) Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Investig Dermatol 129:1016–1025PubMedCrossRef Tjiu JW, Chen JS, Shun CT et al (2009) Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Investig Dermatol 129:1016–1025PubMedCrossRef
23.
go back to reference Chen XJ, Deng YR, Wang ZC et al (2019) Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment. Cell Death Dis 10:508PubMedPubMedCentralCrossRef Chen XJ, Deng YR, Wang ZC et al (2019) Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment. Cell Death Dis 10:508PubMedPubMedCentralCrossRef
24.
go back to reference Chen XJ, Han LF, Wu XG et al (2017) Clinical significance of CD163+ and CD68+ tumor-associated macrophages in high-risk HPV-related cervical cancer. J Cancer 8:3868–3875PubMedPubMedCentralCrossRef Chen XJ, Han LF, Wu XG et al (2017) Clinical significance of CD163+ and CD68+ tumor-associated macrophages in high-risk HPV-related cervical cancer. J Cancer 8:3868–3875PubMedPubMedCentralCrossRef
25.
go back to reference Barash U, Lapidot M, Zohar Y et al (2018) Involvement of heparanase in the pathogenesis of mesothelioma: basic aspects and clinical applications. J Natl Cancer Inst 110:1102–1114PubMedPubMedCentralCrossRef Barash U, Lapidot M, Zohar Y et al (2018) Involvement of heparanase in the pathogenesis of mesothelioma: basic aspects and clinical applications. J Natl Cancer Inst 110:1102–1114PubMedPubMedCentralCrossRef
26.
go back to reference Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8:e1000412PubMedPubMedCentralCrossRef Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8:e1000412PubMedPubMedCentralCrossRef
27.
go back to reference Bajpai R, Nagaraju GP (2017) Specificity protein 1: Its role in colorectal cancer progression and metastasis. Crit Rev Oncol Hematol 113:1–7PubMedCrossRef Bajpai R, Nagaraju GP (2017) Specificity protein 1: Its role in colorectal cancer progression and metastasis. Crit Rev Oncol Hematol 113:1–7PubMedCrossRef
28.
go back to reference Deng YR, Chen XJ, Chen W et al (2019) Sp1 contributes to radioresistance of cervical cancer through targeting G2/M cell cycle checkpoint CDK1. Cancer Manag Res 11:5835–5844PubMedPubMedCentralCrossRef Deng YR, Chen XJ, Chen W et al (2019) Sp1 contributes to radioresistance of cervical cancer through targeting G2/M cell cycle checkpoint CDK1. Cancer Manag Res 11:5835–5844PubMedPubMedCentralCrossRef
30.
go back to reference Weichand B, Popp R, Dziumbla S et al (2017) S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1beta. J Exp Med 214:2695–2713PubMedPubMedCentralCrossRef Weichand B, Popp R, Dziumbla S et al (2017) S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1beta. J Exp Med 214:2695–2713PubMedPubMedCentralCrossRef
31.
go back to reference Bieniasz-Krzywiec P, Martin-Perez R, Ehling M et al (2019) Podoplanin-expressing macrophages promote lymphangiogenesis and lymphoinvasion in breast cancer. Cell Metab 30:917-936.e10PubMedCrossRef Bieniasz-Krzywiec P, Martin-Perez R, Ehling M et al (2019) Podoplanin-expressing macrophages promote lymphangiogenesis and lymphoinvasion in breast cancer. Cell Metab 30:917-936.e10PubMedCrossRef
32.
go back to reference Ip W, Hoshi N, Shouval DS, Snapper S, Medzhitov R (2017) Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356:513–519PubMedPubMedCentralCrossRef Ip W, Hoshi N, Shouval DS, Snapper S, Medzhitov R (2017) Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356:513–519PubMedPubMedCentralCrossRef
33.
go back to reference Mannino MH, Zhu Z, Xiao H et al (2015) The paradoxical role of IL-10 in immunity and cancer. Cancer Lett 367:103–107PubMedCrossRef Mannino MH, Zhu Z, Xiao H et al (2015) The paradoxical role of IL-10 in immunity and cancer. Cancer Lett 367:103–107PubMedCrossRef
34.
go back to reference Hos D, Bucher F, Regenfuss B et al (2016) IL-10 indirectly regulates corneal lymphangiogenesis and resolution of inflammation via macrophages. Am J Pathol 186:159–171PubMedCrossRef Hos D, Bucher F, Regenfuss B et al (2016) IL-10 indirectly regulates corneal lymphangiogenesis and resolution of inflammation via macrophages. Am J Pathol 186:159–171PubMedCrossRef
35.
go back to reference Nakamura R, Sene A, Santeford A et al (2015) IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis. Nat Commun 6:7847PubMedPubMedCentralCrossRef Nakamura R, Sene A, Santeford A et al (2015) IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis. Nat Commun 6:7847PubMedPubMedCentralCrossRef
37.
go back to reference Wang B, Wang H, Li P et al (2018) Relationships of interleukin-10 with the regulatory T cell ratio and prognosis of cervical cancer patients. Clinics 73:e679PubMedPubMedCentralCrossRef Wang B, Wang H, Li P et al (2018) Relationships of interleukin-10 with the regulatory T cell ratio and prognosis of cervical cancer patients. Clinics 73:e679PubMedPubMedCentralCrossRef
38.
go back to reference Ben-Baruch A (2008) Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 25:345–356PubMedCrossRef Ben-Baruch A (2008) Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 25:345–356PubMedCrossRef
39.
go back to reference Knipfer L, Schulz-Kuhnt A, Kindermann M et al (2019) A CCL1/CCR8-dependent feed-forward mechanism drives ILC2 functions in type 2-mediated inflammation. J Exp Med 216:2763–2777PubMedPubMedCentralCrossRef Knipfer L, Schulz-Kuhnt A, Kindermann M et al (2019) A CCL1/CCR8-dependent feed-forward mechanism drives ILC2 functions in type 2-mediated inflammation. J Exp Med 216:2763–2777PubMedPubMedCentralCrossRef
40.
go back to reference Barsheshet Y, Wildbaum G, Levy E et al (2017) CCR8(+)FOXp3(+) Treg cells as master drivers of immune regulation. Proc Natl Acad Sci USA 114:6086–6091PubMedPubMedCentralCrossRef Barsheshet Y, Wildbaum G, Levy E et al (2017) CCR8(+)FOXp3(+) Treg cells as master drivers of immune regulation. Proc Natl Acad Sci USA 114:6086–6091PubMedPubMedCentralCrossRef
41.
go back to reference Sokol CL, Camire RB, Jones MC, Luster AD (2018) The chemokine receptor CCR8 promotes the migration of dendritic cells into the lymph node parenchyma to initiate the allergic immune response. Immunity 49:449–463PubMedPubMedCentralCrossRef Sokol CL, Camire RB, Jones MC, Luster AD (2018) The chemokine receptor CCR8 promotes the migration of dendritic cells into the lymph node parenchyma to initiate the allergic immune response. Immunity 49:449–463PubMedPubMedCentralCrossRef
42.
go back to reference Mukherjee S, Manna A, Bhattacharjee P et al (2016) Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells. Oncogene 35:4937–4948PubMedCrossRef Mukherjee S, Manna A, Bhattacharjee P et al (2016) Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells. Oncogene 35:4937–4948PubMedCrossRef
43.
go back to reference Das S, Sarrou E, Podgrabinska S et al (2013) Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. J Exp Med 210:1509–1528PubMedPubMedCentralCrossRef Das S, Sarrou E, Podgrabinska S et al (2013) Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. J Exp Med 210:1509–1528PubMedPubMedCentralCrossRef
44.
go back to reference Marcuzzi E, Angioni R, Molon B, Cali B (2018) Chemokines and chemokine receptors: orchestrating tumor metastasization. Int J Mol Sci 20:96PubMedCentralCrossRef Marcuzzi E, Angioni R, Molon B, Cali B (2018) Chemokines and chemokine receptors: orchestrating tumor metastasization. Int J Mol Sci 20:96PubMedCentralCrossRef
45.
go back to reference Beishline K, Azizkhan-Clifford J (2015) Sp1 and the “hallmarks of cancer.” FEBS J 282:224–258PubMedCrossRef Beishline K, Azizkhan-Clifford J (2015) Sp1 and the “hallmarks of cancer.” FEBS J 282:224–258PubMedCrossRef
46.
go back to reference Lin C, Song L, Liu A et al (2015) Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma. Oncogene 34:384–393PubMedCrossRef Lin C, Song L, Liu A et al (2015) Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma. Oncogene 34:384–393PubMedCrossRef
47.
go back to reference Hertel J, Hirche C, Wissmann C, Ebert MP, Höcker M (2014) Transcription of the vascular endothelial growth factor receptor-3 (VEGFR3) gene is regulated by the zinc finger proteins Sp1 and Sp3 and is under epigenetic control: transcription of vascular endothelial growth factor receptor 3. Cell Oncol 37:131–145CrossRef Hertel J, Hirche C, Wissmann C, Ebert MP, Höcker M (2014) Transcription of the vascular endothelial growth factor receptor-3 (VEGFR3) gene is regulated by the zinc finger proteins Sp1 and Sp3 and is under epigenetic control: transcription of vascular endothelial growth factor receptor 3. Cell Oncol 37:131–145CrossRef
48.
go back to reference Marin M, Karis A, Visser P, Grosveld F, Philipsen S (1997) Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell 89:619–628PubMedCrossRef Marin M, Karis A, Visser P, Grosveld F, Philipsen S (1997) Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell 89:619–628PubMedCrossRef
49.
go back to reference Yang C, Li J, Yu L et al (2017) Regulation of RIP3 by the transcription factor Sp1 and the epigenetic regulator UHRF1 modulates cancer cell necroptosis. Cell Death Dis 8:e3084PubMedPubMedCentralCrossRef Yang C, Li J, Yu L et al (2017) Regulation of RIP3 by the transcription factor Sp1 and the epigenetic regulator UHRF1 modulates cancer cell necroptosis. Cell Death Dis 8:e3084PubMedPubMedCentralCrossRef
50.
go back to reference Safe S, Abdelrahim M (2005) Sp transcription factor family and its role in cancer. Eur J Cancer 41:2438–2448PubMedCrossRef Safe S, Abdelrahim M (2005) Sp transcription factor family and its role in cancer. Eur J Cancer 41:2438–2448PubMedCrossRef
51.
go back to reference Li L, Davie JR (2010) The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat 192:275–283PubMedCrossRef Li L, Davie JR (2010) The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat 192:275–283PubMedCrossRef
52.
go back to reference Rudno-Rudzinska J, Kielan W, Grzebieniak Z et al (2013) High density of peritumoral lymphatic vessels measured by D2–40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend? Gastric Cancer 16:513–520PubMedCrossRef Rudno-Rudzinska J, Kielan W, Grzebieniak Z et al (2013) High density of peritumoral lymphatic vessels measured by D2–40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend? Gastric Cancer 16:513–520PubMedCrossRef
53.
go back to reference Gordon EJ, Gale NW, Harvey NL (2008) Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels. Dev Dyn 237:1901–1909PubMedCrossRef Gordon EJ, Gale NW, Harvey NL (2008) Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels. Dev Dyn 237:1901–1909PubMedCrossRef
54.
go back to reference Lim HY, Lim SY, Tan CK et al (2018) Hyaluronan receptor LYVE-1-expressing macrophages maintain arterial tone through hyaluronan-mediated regulation of smooth muscle cell collagen. Immunity 49:326–341PubMedCrossRef Lim HY, Lim SY, Tan CK et al (2018) Hyaluronan receptor LYVE-1-expressing macrophages maintain arterial tone through hyaluronan-mediated regulation of smooth muscle cell collagen. Immunity 49:326–341PubMedCrossRef
Metadata
Title
A novel lymphatic pattern promotes metastasis of cervical cancer in a hypoxic tumour-associated macrophage-dependent manner
Authors
Xiao-Jing Chen
Wen-Fei Wei
Zi-Ci Wang
Nisha Wang
Chu-Hong Guo
Chen-Fei Zhou
Luo-Jiao Liang
Sha Wu
Li Liang
Wei Wang
Publication date
01-08-2021
Publisher
Springer Netherlands
Keyword
Metastasis
Published in
Angiogenesis / Issue 3/2021
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-020-09766-2

Other articles of this Issue 3/2021

Angiogenesis 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.